Tuesday, August 11, 2026

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Federal Reserve Freezes Interest Rates as Chair Jerome Powell Remains on the Board

The Fed holds rates steady amid dissent, rising oil prices, and Powell's decision to stay on the board, highlighting internal divisions.

U.S. Embassy in Seoul Opens Condolence Book for Jimmy Carter—Find Out How to Sign It

The U.S. Embassy in South Korea offers a condolence book for mourners following Jimmy Carter's passing, with specific visiting hours.

Tag: Oscotec

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Cevidoplenib: The Game-Changing Autoimmune Drug Set for Global Launch in 2026

Oscotec's Cevidoplenib, an autoimmune drug, is set for global development with Agios, promising significant growth and revenue potential.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.